Here, we found that Tau alters other neuronal pathways associated with stages preceding severe AD pathology that are characterized by higher Tau levels in turn (Kurbatskaya et al., 2016; Han et al., 2017). This evidence concerns the gene MAPT and Alzheimer disease.